System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Optimizing Therapeutic Index (TI) by Exploring Co-Dependencies of Target and Therapeutic Properties: Madhu Natarajan, PhD

DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD »

System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

William Reinhold, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/Reinhold_William.pdf

Advertisements

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Computational Biology/Systems and Bioinformatics | 1 Comment

One Response

on April 20, 2014 at 6:19 PM | Reply Cancer Research: Curations and Reporting: Aviva Lev-Ari, PhD, RN | Pharmaceutical Intelligence

[…] https://pharmaceuticalintelligence.com/2013/04/22/system-pharmacology-using-cellminer-and-the-nci-60-… […]

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: